Linfoma: epidemiología y clasificación actual. Trabajo de actualización

Caviglia, Silvia; Chuchurru, Jorge.
Rev. Asoc. Odontol. Argent ; 95(1): 47-49, ene.-mar. 2007.
Artículo en Español | LILACS | ID: lil-462719

Documentos relacionados

  1. [Epigenetic abnormalities in non-Hodgkin lymphomas].
  2. A case of non-Hodgkin lymphoma of the upper gingiva with minimal residual disease detected in cryopreserved ovarian tissue: A case report.
  3. The forgotten survivor: A comprehensive review on Non-Hodgkin lymphoma survivorship.
  4. Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature.
  5. Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol.
  6. Drug Resistance in Non-Hodgkin Lymphomas.
  7. Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition.
  8. [Clinical analysis of 7 cases of pregnancy with non-Hodgkin lymphoma].
  9. [Expression and significance of jumonji domain-containing protein 2B and hypoxia inducible factor-1α in non-Hodgkin lymphoma tissues in children].
  10. Environmental pesticide exposure and non-Hodgkin lymphoma survival: a population-based study.